WHO recommends 4th dose of vaccination

Armda
2021-12-22

Dec 21 (Reuters) - Novavax said on Tuesday the World Health Organization's (WHO) panel of experts had recommended a third dose of its vaccine, NVX-CoV2373, for immunocompromised persons.

The WHO's Strategic Advisory Group of Experts on Immunization, known as SAGE, issued a series of recommendations, including the use of the vaccine in persons with comorbidities, breastfeeding women, and those living with HIV.

After reviewing Novavax data the independent experts said the vaccine could be used in pregnant women if the benefits of vaccination to the pregnant woman outweigh the potential risks.

On Friday, the WHO issued an emergency use listing to Novavax's vaccine made by the Serum Institute of India, the world's biggest vaccine maker, paving the way for its use in low- and middle-income countries where rollout has been much slower than in Europe.

Novavax said on Monday it had received the WHO's emergency use listing for the company's own version of the vaccine, which it will distribute in Europe and other markets.

The company also said on Tuesday it had begun administering its first booster doses of NVX-CoV2373 in a late-stage trial. (Reporting by Dania Nadeem in Bengaluru; Editing by Maju Samuel)

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

举报

评论（6）

  • 推荐
  • 最新
  • RodBeard
    ·2021-12-22
    This is important for the global economic recovery in 2022.
    回复
    举报
  • falleno
    ·2021-12-22
    Vaccination benefits everyone in the world. The global economy needs recovery. I believe the epidemic will be completely eliminated in 2022.
    回复
    举报
  • keepcalm
    ·2021-12-22
    Novavax is a great company.
    回复
    举报
  • RonaldNixon
    ·2021-12-22
    Vaccination is good for everyone. Global economy needs to recover as soon as possible.
    回复
    举报
  • waipoin
    ·2021-12-22
    When will the world develop the most effective vaccine?
    回复
    举报